| |
|
| |
| DETAILS |
|
Please Join PCI in San Francisco this January for
Innovation @ Penn: Precision Medicine
Translating Discovery into Targeted Therapies
PCI is hosting our Innovation @ Penn program in San Francisco on January 12, 2026, at 3 pm. This signature event, held concurrently during the annual JP Morgan Healthcare Conference, is an excellent opportunity to learn about emerging areas of innovation & opportunities for partnership with Penn. The program attracts professionals from across the life science industry, the investor community, & other stakeholders, & provides a platform for in-depth discussions about emerging healthcare technologies & their practical applications.
PCI is honored to have an outstanding group of participants, including leading luminaries:
Peter Marks, MD, PhD, Senior Vice President of Molecule Discovery & Head of Infectious Disease at Eli Lilly, & former Director of the FDA's Center for Biologics Evaluation & Research
Jim Wilson, MD, PhD, Emeritus Professor of Medicine (Translation of Medicine & Human Genetics) at Penn Medicine, Founder & CEO of Gemma Biotherapeutics, & Founder & Executive Chair of Franklin Biolabs
Allison Rae Greenplate, PhD, Adjunct Assistant Professor of Systems Pharmacology & Translational Therapeutics & Director of Immune Health at Penn Medicine
Laura Shawver, PhD, former President & CEO of Capstan Therapeutics, will serve as moderator of the panel
Jonathan Epstein, MD, PhD, Dean, Perelman School of Medicine & Executive Vice President of the University of Pennsylvania for the Health System, will deliver keynote remarks
More details & registration information can be found below. Please join us!
|
|
|
|
|
|
|
|
